ICL (NYSE: ICL) announced first-quarter earnings on Monday that missed analyst estimates, with revenue declining more than anticipated. The fertilizer and specialty chemicals company’s shares fell 1.93% in pre-market trading following the report.
ICL posted adjusted earnings per share (EPS) of $0.09 for the quarter, below the consensus estimate of $0.10. Revenue came in at $1.77 billion, missing analyst projections of $1.85 billion and declining compared to the same period last year.
Despite the quarterly shortfall, the company reaffirmed its full-year 2025 guidance, expecting specialties-driven EBITDA between $950 million and $1.15 billion. It also maintained its forecast for potash sales volumes of 4.5 million to 4.7 million metric tons.
The reaffirmed full-year outlook may have helped cushion the stock’s decline. ICL highlighted its focus on expanding its specialty products business and optimizing costs across operations. The company aims to drive growth through innovation and new product development within its industrial products and advanced additives segments.